(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 835.64 | 910.82 | -8.25 | 835.64 | 910.82 | -8.25 | 4481.46 | 3813.04 | 17.53 |
| Other Income | 7.08 | 4.87 | 45.38 | 7.08 | 4.87 | 45.38 | 49.89 | 55.58 | -10.24 |
| PBIDT | 0.47 | -104.97 | -100.45 | 0.47 | -104.97 | -100.45 | 4.84 | -606.36 | -100.80 |
| Interest | 77.40 | 110.49 | -29.95 | 77.40 | 110.49 | -29.95 | 345.68 | 367.07 | -5.83 |
| PBDT | -76.93 | -215.46 | -64.29 | -76.93 | -215.46 | -64.29 | -361.78 | -973.43 | -62.83 |
| Depreciation | 110.86 | 115.10 | -3.68 | 110.86 | 115.10 | -3.68 | 449.93 | 437.74 | 2.78 |
| PBT | -187.79 | -330.56 | -43.19 | -187.79 | -330.56 | -43.19 | -811.71 | -1411.17 | -42.48 |
| TAX | -0.41 | 0.00 | 0.00 | -0.41 | 0.00 | 0.00 | -1.63 | -63.10 | -97.42 |
| Deferred Tax | -0.41 | 0.00 | 0.00 | -0.41 | 0.00 | 0.00 | -1.63 | -63.10 | -97.42 |
| PAT | -187.38 | -330.56 | -43.31 | -187.38 | -330.56 | -43.31 | -810.08 | -1348.07 | -39.91 |
| Equity | 222.83 | 196.12 | 13.62 | 222.83 | 196.12 | 13.62 | 222.82 | 196.11 | 13.62 |
| PBIDTM(%) | 0.06 | -11.52 | -100.49 | 0.06 | -11.52 | -100.49 | 0.11 | -15.90 | -100.68 |
| Company Name | CMP |
|---|---|
| UPL | 625.00 |
| PI Industries | 2830.00 |
| Bayer CropScience | 4299.80 |
| Sharda Cropchem | 827.80 |
| Sumitomo Chem. India | 515.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: